Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
D000014:Abnormalities, Drug-Induced; D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002066:Busulfan / Q000009:adverse effects; D002273:Carcinogens; D002493:Central Nervous System Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D008599:Menstruation Disturbances / Q000139:chemically induced; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D009381:Neoplasms, Radiation-Induced; D011247:Pregnancy; D011878:Radiotherapy / Q000009:adverse effects; D001745:Urinary Bladder Diseases / Q000139:chemically induced
D000970:Antineoplastic Agents; D002273:Carcinogens; D015122:Mercaptopurine; D002066:Busulfan; D008727:Methotrexate